1
|
Khan SA, Emadossadaty S, Ladep NG, Thomas
HC, Elliott P, Taylor-Robinson SD and Toledano MB: Rising trends in
cholangiocarcinoma: Is the ICD classification system misleading us?
J Hepatol. 56:848–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
DeOliveira ML, Cunningham SC, Cameron JL,
Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick
RD: Cholangiocarcinoma: Thirty-one-year experience with 564
patients at a single institution. Ann Surg. 245:755–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
3
|
van der Gaag NA, Kloek JJ, de Bakker JK,
Musters B, Geskus RB, Busch OR, Bosma A, Gouma DJ and van Gulik TM:
Survival analysis and prognostic nomogram for patients undergoing
resection of extrahepatic cholangiocarcinoma. Ann Oncol.
23:2642–2649. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sun M, Jin FY, Xia R, Kong R, Li JH, Xu
TP, Liu YW, Zhang EB, Liu XH and De W: Decreased expression of long
noncoding RNA GAS5 indicates a poor prognosis and promotes cell
proliferation in gastric cancer. BMC Cancer. 14:3192014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Prensner JR, Chen W, Han S, Iyer MK, Cao
Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, et al:
The long non-coding RNA PCAT-1 promotes prostate cancer cell
proliferation through cMyc. Neoplasia. 16:900–908. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian
J, Zhang X and Fang JY: A long non-coding RNA signature to improve
prognosis prediction of colorectal cancer. Oncotarget. 5:2230–2242.
2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sun J, Chen X, Wang Z, Guo M, Shi H, Wang
X, Cheng L and Zhou M: A potential prognostic long non-coding RNA
signature to predict metastasis-free survival of breast cancer
patients. Sci Rep. 5:165532015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhou M, Guo M, He D, Wang X, Cui Y, Yang
H, Hao D and Sun J: A potential signature of eight long non-coding
RNAs predicts survival in patients with non-small cell lung cancer.
J Transl Med. 13:2312015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhou M, Zhao H, Wang Z, Cheng L, Yang L,
Shi H, Yang H and Sun J: Identification and validation of potential
prognostic lncRNA biomarkers for predicting survival in patients
with multiple myeloma. J Exp Clin Cancer Res. 34:1022015.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Cheng N, Li X, Zhao C, Ren S, Chen X, Cai
W, Zhao M, Zhang Y, Li J, Wang Q and Zhou C: Microarray expression
profile of long non-coding RNAs in EGFR-TKIs resistance of human
non-small cell lung cancer. Oncol Rep. 33:833–839. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Li C, Liang G, Yao W, Sui J, Shen X, Zhang
Y, Ma S, Ye Y, Zhang Z, Zhang W, et al: Differential expression
profiles of long non-coding RNAs reveal potential biomarkers for
identification of human gastric cancer. Oncol Rep. 35:1529–1540.
2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Luo J, Xu L, Jiang Y, Zhuo D, Zhang S, Wu
L, Xu H and Huang Y: Expression profile of long non-coding RNAs in
colorectal cancer: A microarray analysis. Oncol Rep. 35:2035–2044.
2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Qiu JJ, Ye LC, Ding JX, Feng WW, Jin HY,
Zhang Y, Li Q and Hua KQ: Expression and clinical significance of
estrogen-regulated long non-coding RNAs in estrogen receptor
α-positive ovarian cancer progression. Oncol Rep. 31:1613–1622.
2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jia H, Osak M, Bogu GK, Stanton LW,
Johnson R and Lipovich L: Genome-wide computational identification
and manual annotation of human long noncoding RNA genes. RNA.
16:1478–1487. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Sun J, Zhou M, Mao ZT, Hao DP, Wang ZZ and
Li CX: Systematic analysis of genomic organization and structure of
long non-coding RNAs in the human genome. FEBS Lett. 587:976–982.
2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Martens-Uzunova ES, Bottcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang J, Xie H, Ling Q, Lu D, Lv Z, Zhuang
R, Liu Z, Wei X, Zhou L, Xu X and Zheng S: Coding-noncoding gene
expression in intrahepatic cholangiocarcinoma. Transl Res.
168:107–121. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
ICD-O-Cs (International Classification of
Diseases-Oncology-Czech edition). Cesk Patol. 19:228–250. 1983.(In
Czech). PubMed/NCBI
|
23
|
Bradley LA, Palomaki GE, Gutman S, Samson
D and Aronson N: Comparative effectiveness review: Prostate cancer
antigen 3 testing for the diagnosis and management of prostate
cancer. J Urol. 190:389–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Raveh E, Matouk IJ, Gilon M and Hochberg
A: The H19 Long non-coding RNA in cancer initiation, progression
and metastasis-a proposed unifying theory. Mol Cancer. 14:1842015.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin
L, Chen WM, Han L, Zhang EB, Kong R, et al: Decreased expression of
the long non-coding RNA FENDRR is associated with poor
prognosis in gastric cancer and FENDRR regulates gastric
cancer cell metastasis by affecting fibronectin1 expression. J
Hematol Oncol. 7:632014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhu J, Fu H, Wu Y and Zheng X: Function of
lncRNAs and approaches to lncRNA-protein interactions. Sci China
Life Sci. 56:876–885. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Wang X and El Naqa IM: Prediction of both
conserved and nonconserved microRNA targets in animals.
Bioinformatics. 24:325–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction
networks from large-scale CLIP-Seq data. Nucleic Acids Res.
42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jeggari A, Marks DS and Larsson E:
miRcode: A map of putative microRNA target sites in the long
non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Yongvanit P, Phanomsri E, Namwat N, Kampan
J, Tassaneeyakul W, Loilome W, Puapairoj A and Khuntikeo N: Hepatic
cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of
patients with Opisthorchis viverrini-associated cholangiocarcinoma.
Parasitol Int. 61:162–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Prawan A, Kukongviriyapan V, Tassaneeyakul
W, Pairojkul C and Bhudhisawasdi V: Association between genetic
polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and
susceptibility to cholangiocarcinoma. Eur J Cancer Prev.
14:245–250. 2005. View Article : Google Scholar : PubMed/NCBI
|